GE Analytical Instruments
based in Boulder, COLORADO (USA)
The dietary supplement and nutraceutical market is changing rapidly in response to the FDA`s new Dietary Supplement Current Good Manufacturing Practices (cGMPS) `Final Rule` (21 CFR Part 111), published on June 25, 2007. The Final Rule adopts all requirements specified in 21 CFR 210 and 211, which affect pharmaceutical manufacturers, and apply to all companies that manufacture, package, label, or hold dietary supplements and nutraceuticals. Dietary supplements or nutraceuticals imported from outside the United States are also subject to the Final Rule.